首页> 外文期刊>BMC Pediatrics >Elective high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome: an individual patient data meta-analysis
【24h】

Elective high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome: an individual patient data meta-analysis

机译:呼吸窘迫综合征早产儿的高频高频振荡通气:一项单独的患者数据荟萃分析

获取原文
           

摘要

Background Despite the considerable amount of evidence from randomized controlled trials and meta-analyses, uncertainty remains regarding the efficacy and safety of high-frequency oscillatory ventilation as compared to conventional ventilation in the early treatment of respiratory distress syndrome in preterm infants. This results in a wide variation in the clinical use of high-frequency oscillatory ventilation for this indication throughout the world. The reasons are an unexplained heterogeneity between trial results and a number of unanswered, clinically important questions. Do infants with different risk profiles respond differently to high-frequency oscillatory ventilation? How does the ventilation strategy affect outcomes? Does the delay – either from birth or from the moment of intubation – to the start of high-frequency oscillation modify the effect of the intervention? Instead of doing new trials, those questions can be addressed by re-analyzing the individual patient data from the existing randomized controlled trials. Methods/Design A systematic review with meta-analysis based on individual patient data. This involves the central collection, validation and re-analysis of the original individual data from each infant included in each randomized controlled trial addressing this question. The study objective is to estimate the effect of high-frequency oscillatory ventilation on the risk for the combined outcome of death or bronchopulmonary dysplasia or a severe adverse neurological event. In addition, it will explore whether the effect of high-frequency oscillatory ventilation differs by the infant's risk profile, defined by gestational age, intrauterine growth restriction, severity of lung disease at birth and whether or not corticosteroids were given to the mother prior to delivery. Finally, it will explore the importance of effect modifying factors such as the ventilator device, ventilation strategy and the delay to the start of high-frequency ventilation. Discussion An international collaborative group, the PreVILIG Collaboration (Prevention of Ventilator Induced Lung Injury Group), has been formed with the investigators of the original randomized trials to conduct this systematic review. In the field of neonatology, individual patient data meta-analysis has not been used previously. Final results are expected to be available by the end of 2009.
机译:背景技术尽管有来自随机对照试验和荟萃分析的大量证据,但在早产儿呼吸窘迫综合征的早期治疗中,与常规通气相比,高频振荡通气的疗效和安全性仍不确定。这导致在世界范围内针对这种适应症的高频振荡通气的临床使用存在很大差异。原因是试验结果与许多未解决的临床重要问题之间存在无法解释的异质性。具有不同风险特征的婴儿对高频振荡通气的反应是否不同?通风策略如何影响结果?从出生或插管开始到高频振荡开始的延迟是否会改变干预效果?可以通过重新分析现有随机对照试验中的各个患者数据来解决这些问题,而不必进行新的试验。方法/设计基于个体患者数据进行荟萃分析的系统评价。这涉及集中收集,验证和重新分析来自每个婴儿的原始个人数据,这些原始数据包含在每个随机对照试验中,以解决这一问题。研究目的是评估高频振荡通气对死亡或支气管肺发育不良或严重不良神经系统事件的综合结果风险的影响。此外,它将探讨高频振荡通气的效果是否因婴儿的风险状况而不同,婴儿的风险状况由胎龄,子宫内生长受限,出生时肺部疾病的严重性以及分娩前是否给母亲服用糖皮质激素定义。最后,它将探讨影响修改因素的重要性,例如通风设备,通风策略以及高频通风启动的延迟。讨论与原始随机试验的研究者一起,组成了国际协作小组PreVILIG协作(预防呼吸机诱发的肺损伤小组)进行了系统的综述。在新生儿科领域,以前从未使用过单个患者数据的荟萃分析。最终结果有望在2009年底前公布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号